Document is current
Any future updates will be listed below
-
Authors
Azabdaftari, Aline
Jones, Kelsey D. J.
Kammermeier, Jochen
Uhlig, Holm H.
-
Funding
Funding for this research was provided by:
NIHR Oxford Biomedical Research Centre
Leona M. and Harry B. Helmsley Charitable Trust
Crohn’s in Childhood Research Association
Medical Research Council
Deutsche Forschungsgemeinschaft (AZ 167/1-1)
Janssen Pharmaceuticals
UCB UK
Eli Lilly and Company
Bristol-Myers Squibb
MiroBio
OMass
Mestag
- License Information
-
More Information
Article History
Received: 10 February 2022
Accepted: 3 June 2022
First Online: 28 June 2022
Declarations
:
: NIHR Oxford Biomedical Research Centre, Leona M. and Harry B. Helmsley Charitable Trust, Crohn’s in Childhood Research Association, Medical Research Council,Deutsche Forschungsgemeinschaft, project number 501883972, Janssen Pharmaceuticals, UCB UK, Eli Lilly and Company, Bristol-Myers Squibb, MiroBio, OMass, Mestag.
: HHU has received research support or consultancy fees from Janssen, UCB Pharma, Eli Lilly, BMS/Celgene, MiroBio, OMass, Mestag. AA was funded by an Oxford-BMS fellowship.
